These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1164711)

  • 21. [Changes of the activity of enzymes in the blood serum in patients with porphyria cutanea tarda].
    Smirnov VS
    Vestn Dermatol Venerol; 1973 Oct; 47(10):29-33. PubMed ID: 4782172
    [No Abstract]   [Full Text] [Related]  

  • 22. [Porhyria cutanea tarda in hereditary bullous epidermolysis type Weber-Cockayne].
    Nuss A; Petres J
    Z Hautkr; 1974 Apr; 49(7):273-80. PubMed ID: 4836325
    [No Abstract]   [Full Text] [Related]  

  • 23. [Total and HDL lipoprotein fraction-bound cholesterol levels in patients with acute hepatic porphyria].
    Letowska M; Kierczuk I; Miedzianowska I; Kolasińska-Kramer M
    Pol Tyg Lek; 1986 Jul; 41(28):883-5. PubMed ID: 3763465
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of autoantibodies in patients with porphyria cutanea tarda].
    Plechistova LA; Vybornov VA
    Vestn Dermatol Venerol; 1974 Jun; 0(6):32-6. PubMed ID: 4278569
    [No Abstract]   [Full Text] [Related]  

  • 25. Iron metabolism in porphyria cutanea tarda and in erythropoietic protoporphyria.
    Turnbull A; Baker H; Vernon-Roberts B; Magnus IA
    Q J Med; 1973 Apr; 42(166):341-55. PubMed ID: 4785438
    [No Abstract]   [Full Text] [Related]  

  • 26. [Blood coagulation system in patients with porphyria cutanea tarda].
    Tsygankova EP
    Vestn Dermatol Venerol; 1979 Feb; (2):11-3. PubMed ID: 425680
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the problem of iron metabolism in porphyria cutanea tarda].
    Schnack H
    Wien Z Inn Med; 1966 Nov; 47(11):447-53. PubMed ID: 6005179
    [No Abstract]   [Full Text] [Related]  

  • 28. [Serum non-hemoglobin iron levels in patients with porphyria cutanea tarda].
    Kapralov IK
    Vestn Dermatol Venerol; 1967 Jul; 41(7):44-6. PubMed ID: 5621108
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of venesection therapy on liver tissue in porphyria cutanea tarda.
    Chlumský J; Malina L; Chlumská A
    Acta Hepatogastroenterol (Stuttg); 1973; 20(2):124-30. PubMed ID: 4751154
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of patients with porphyria cutanea tarda with antimalarials].
    Kordac V; Semrádová M
    Cas Lek Cesk; 1973; 112(24):762-5. PubMed ID: 4714507
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatic porphyrias. Cytochemical and ultrastructural studies of liver in acute intermittent porphyria and porphyria cutanea tarda.
    Biempica L; Kosower N; Ma MH; Goldfischer S
    Arch Pathol; 1974 Nov; 98(5):336-43. PubMed ID: 4413664
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemopexin metabolism in patients with altered serum levels.
    Foidart M; Liem HH; Adornato BT; Engel WK; Muller-Eberhard U
    J Lab Clin Med; 1983 Nov; 102(5):838-46. PubMed ID: 6631174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Needle-like cytoplasmic inclusions in the liver in prophyria cutanea tarda.
    Waldo ED; Tobias H
    Arch Pathol; 1973 Dec; 96(6):368-71. PubMed ID: 4361707
    [No Abstract]   [Full Text] [Related]  

  • 34. [Concentration of serum transferrin in patients with porphyria cutanea tarda].
    Kansky A
    Hautarzt; 1970 Apr; 21(4):165-6. PubMed ID: 5524562
    [No Abstract]   [Full Text] [Related]  

  • 35. [Porphyrin metabolic disorders in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1989; (8):67-71. PubMed ID: 2816038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chloroquine in the treatment of porphyria cutanea tarda symptomatica. Twelve years of experience in 307 patients (author's transl)].
    Kordac V; Martásek P; Kaláb M; Semrádová M; Papezová R
    Cas Lek Cesk; 1981 Oct; 120(40):1225-7. PubMed ID: 7344792
    [No Abstract]   [Full Text] [Related]  

  • 37. [Quantitative evaluation of transport proteins in various porphyrinopathies and their statistical correlations].
    Amantea A; D'Alessandro Gandolfo L; Topi G
    Quad Sclavo Diagn; 1982 Mar; 18(1):53-66. PubMed ID: 7156333
    [No Abstract]   [Full Text] [Related]  

  • 38. [Alpha-1-fetal protein in patients with porphyria cutanea tarda].
    Kordac V; Zizkovský V
    Cas Lek Cesk; 1974 May; 113(20):629-32. PubMed ID: 4141641
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnostic significance of serum hemopexin in patients with malignant melanoma].
    Popović S; Roguljić A; Nola P; Maricić Z
    Lijec Vjesn; 1975; 97(4):241-4. PubMed ID: 1177660
    [No Abstract]   [Full Text] [Related]  

  • 40. [Occurrence of circulating autoantibodies in porphyria cutanea tarda].
    Köstler E; Storz H; Seebacher C
    Dermatol Monatsschr; 1985; 171(4):236-9. PubMed ID: 3891435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.